Pier Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Pier Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,203	Closed	-$3.83M	–	120
2022 Q3	$3.83M	Hold	200,203	–	–	0.66%	74
2022 Q2	$3.06M	Sell	200,203 -365	-0.2%	-$5.4K	0.52%	83
2022 Q1	$4.09M	Buy	200,568 +3,003	+2%	+$61.1K	0.52%	87
2021 Q4	$5.76M	Sell	197,565 -163,722	-45%	-$4.69M	0.61%	83
2021 Q3	$7.79M	Sell	361,287 -112,992	-24%	-$2.73M	0.81%	71
2021 Q2	$12.2M	Sell	474,279 -119,658	-20%	-$2.56M	1.22%	19
2021 Q1	$10.8M	Sell	593,937 -133,887	-18%	-$2.22M	1.03%	60
2020 Q4	$8.4M	Buy	727,824 +270,714	+59%	+$2.47M	0.89%	74
2020 Q3	$3.48M	Buy	+457,110	New	+$3.46M	0.51%	95

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Pier Capital's CDMO Position: Q4 2022 in Review

Pier Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 200,203 shares — an estimated $3.83M sold.

Pier Capital first reported a position in CDMO in Q3 2020 and held it in 9 quarters. The position peaked at $12.2M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

Pier Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Pier Capital sold 200,203 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $3.83M.
Pier Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Pier Capital's Avid Bioservices, Inc. Common Stock position peaked at $12.2M in Q2 2021.
168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Pier Capital's 13F filing for Q4 2022, filed 15 Feb 2023.